Rethinking procurement biopsy in donors with normal renal function: A barrier to kidney utilization without survival benefit

BACKGROUND Procurement biopsy remains widely used in deceased donor kidney transplantation, yet its value is uncertain in kidneys with preserved renal function. Concerns persist regarding sampling error, interpretive variability, and the potential for biopsy findings to contribute directly to organ discard. Whether procurement biopsy improves decision-making or graft outcomes in donors with normal renal function is not known. AIM To investigate whether biopsy adds clinical value or causes delay,